Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in LB Pharmaceuticals
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in LB PHARMACEUTICALS INC, holding 1,277,776 shares of common stock.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.02% Stake in KKR & Co. Inc.
BlackRock, Inc. has reported a beneficial ownership of 5.02% of KKR & Co. Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 6.2% Stake in Lightbridge Corp
BlackRock, Inc. has filed a Schedule 13G, reporting a 6.2% beneficial ownership stake in Lightbridge Corp's common stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 7.1% Stake in Sezzle Inc.
BlackRock, Inc. has reported a 7.1% beneficial ownership stake in Sezzle Inc. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Trims Protara Therapeutics Stake to 4.7%
BlackRock, Inc. has reported a beneficial ownership of 4.7% in Protara Therapeutics, Inc. common stock, indicating a reduction from a previously held higher stake.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in Ramaco Resources
BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Ramaco Resources, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in Mamas Creations Inc.
BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Mamas Creations Inc. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in MarketWise, Inc.
BlackRock, Inc. has reported a 5.2% beneficial ownership stake in MarketWise, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Cuts Sable Offshore Stake to 4.6%
BlackRock, Inc. has reduced its beneficial ownership in Sable Offshore Corp's Class A Stock to 4.6% as of December 31, 2025, triggering an amendment to its Schedule 13G filing.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.5% Stake in Nextdoor Holdings
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in Nextdoor Holdings, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in NerdWallet Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.3% of NerdWallet, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Molina Healthcare Stake Disclosure
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 6.9% beneficial ownership stake in Molina Healthcare Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reduces MetroCity Bankshares Stake Below 5%
BlackRock, Inc. has reported a beneficial ownership of 4.6% in MetroCity Bankshares Inc. common stock, falling below the 5% threshold.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Jacobs Solutions Stake to 7.7%
BlackRock, Inc. has reported an increased beneficial ownership of 7.7% in Jacobs Solutions Inc. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Sotera Health to 6.2%
BlackRock, Inc. has disclosed an increased beneficial ownership of 6.2% in Sotera Health Co., holding over 17.7 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Devon Energy Stake to 7.9%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 7.9% beneficial ownership stake in Devon Energy Corporation as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Hilton Stake to 8.3%
BlackRock, Inc. has reported an 8.3% beneficial ownership stake in Hilton Worldwide Holdings Inc., holding over 19 million shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in Hallador Energy
BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Hallador Energy Co., totaling 2,270,441 shares of common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Guardian Pharmacy Stake Disclosure
BlackRock, Inc. filed an amended Schedule 13G disclosing its beneficial ownership of 4.2% of Guardian Pharmacy Services, Inc. Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains 5.1% Stake in WPP PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in WPP PLC as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Akamai Stake to 7.0%
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 7.0% beneficial ownership stake in Akamai Technologies Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in MBX Biosciences
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in MBX Biosciences Inc. common stock, held for ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.9% Stake in LENZ THERAPEUTICS
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.9% of LENZ THERAPEUTICS, INC.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Kodiak Gas Services to 14%
BlackRock, Inc. has increased its beneficial ownership in Kodiak Gas Services, Inc. to 14.0% of common stock, holding 11,969,209 shares.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in iShares Bond ETF
BlackRock, Inc. reported an 8.3% beneficial ownership in the iShares Core Universal USD Bond ETF, holding over 61 million shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 6.1% Stake in iShares GNMA Bond ETF
BlackRock, Inc. has reported a 6.1% beneficial ownership stake in iShares GNMA Bond ETF, holding 547,788 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Stake in Molson Coors
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Molson Coors Beverage Co. Class B Stock, totaling 10,217,118 shares.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.01% Stake in Sight Sciences
BlackRock, Inc. has reported a beneficial ownership of 5.01% of Sight Sciences, Inc.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Repay Holdings to 6.1%
BlackRock, Inc. has disclosed a 6.1% beneficial ownership stake in Repay Holdings Corporation's Class A Stock, as detailed in its latest Schedule 13G filing.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in Red Cat Holdings
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.3% of Red Cat Holdings, Inc.'s common stock.